...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >A target for antiangiogenic therapy: Vascular endothelium derived from glioblastoma
【24h】

A target for antiangiogenic therapy: Vascular endothelium derived from glioblastoma

机译:抗血管生成治疗的目标:源自胶质母细胞瘤的血管内皮

获取原文
获取原文并翻译 | 示例
           

摘要

Glioblastoma is the most frequent primary brain tumor in the adult, accounting for 53.8% of all gliomas, and it is one of the most deadly among all human tumors. Despite aggressive treatment at diagnosis, consisting of resection followed by radiation with concurrent and subsequent adjuvant chemotherapy with temozolomide, the tumor almost invariably recurs or progresses, with a patient median survival of 14.6 mo (1). The hallmark of glioblastoma that distinguishes it from all of the other glial tumors is microvascular proliferation in conjunction with necrosis.
机译:胶质母细胞瘤是成人中最常见的原发性脑肿瘤,占所有神经胶质瘤的53.8%,它是所有人类肿瘤中最致命的肿瘤之一。尽管在诊断时采取积极的治疗措施,包括切除,放疗,同时进行替莫唑胺辅助化疗,但肿瘤几乎总是复发或进展,患者中位生存期为14.6 mo(1)。胶质母细胞瘤区别于所有其他神经胶质瘤的标志是微血管增生和坏死。

著录项

  • 来源
  • 作者单位

    Howard Hughes Medical Institute, Ansary Stem Cell Institute, and Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10021 Department of Neurology and Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065 Department of Neurology, Weill Cornell Medical College, New York, NY 10021;

    Howard Hughes Medical Institute, Ansary Stem Cell Institute, and Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10021;

    Howard Hughes Medical Institute, Ansary Stem Cell Institute, and Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10021;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号